← Leaderboards
Wayne W Poon
University Of California-Irvine
$7,008,264
Attributed
$7,008,264
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2014–25$2.5M$1.9M$1.3M$625K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,008,264 · 6
By mechanism
RF1$2,207,391 · 1
P01$1,438,355 · 1
R01$1,435,522 · 1
R41$1,000,000 · 2
P50$926,996 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California-Irvine
Same institution · by research overlap
- Mathew Mark Blurton-Jones$14,315,430
- Hayk Davtyan$2,871,844
- Shivashankar Othy$1,988,640
- Xiaolin Zi$5,893,861
- Xiangmin Xu$44,991,808
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposInduced Pluripotent Stem CellGenesS DiseaseSynapsesAmyloidInnovationDementiaNeuropathologyNeurofibrillary TanglesGenome Wide Association StudyBrainLate Onset Alzheimer DiseaseNeuronsMouse ModelNeuroinflammationIn VivoCellsTau ProteinsGeneticRisk FactorsCollaborationsNeuronal PlasticityPathogenesis
Grant awards (15)
Cell autonomous and non-cell autonomous phenotypes due to genetic risk for late onset Alzheimers disease$708,568
R01 · FY2025 · AG · contact PI
Cell autonomous and non-cell autonomous phenotypes due to genetic risk for late onset Alzheimers disease$726,954
R01 · FY2024 · AG · contact PI
NanoLuciferase-based AD/ADRD Microphysiological Systems Platform for High-throughput Screening$500,000
R41 · FY2024 · AG · contact PI
Miniaturized AD/ADRD Microphysiological Systems Platform for High-throughput Screening$500,000
R41 · FY2023 · AG · contact PI
Cell autonomous and non-cell autonomous phenotypes due to genetic risk for late onset Alzheimers disease$2,207,391
RF1 · FY2021 · AG · contact PI
The Role of ApoE in Neuroplasticity and A-beta; Clearance using iPS Cell-Derived Astrocytes$185,399
P50 · FY2019 · AG · contact PI
TISSUE, PEPTIDE AND GENETICS RESOURCE CORE$284,464
P01 · FY2018 · AG · contact PI
The Role of ApoE in Neuroplasticity and A-beta; Clearance using iPS Cell-Derived Astrocytes$185,400
P50 · FY2018 · AG · contact PI
TISSUE, PEPTIDE AND GENETICS RESOURCE CORE$284,467
P01 · FY2017 · AG · contact PI
The Role of ApoE in Neuroplasticity and A-beta; Clearance using iPS Cell-Derived Astrocytes$185,397
P50 · FY2017 · AG · contact PI
TISSUE, PEPTIDE AND GENETICS RESOURCE CORE$300,827
P01 · FY2016 · AG · contact PI
The Role of ApoE in Neuroplasticity and A-beta; Clearance using iPS Cell-Derived Astrocytes$185,400
P50 · FY2016 · AG · contact PI
TISSUE, PEPTIDE AND GENETICS RESOURCE CORE$275,932
P01 · FY2015 · AG · contact PI
The Role of ApoE in Neuroplasticity and A-beta; Clearance using iPS Cell-Derived Astrocytes$185,400
P50 · FY2015 · AG · contact PI
TISSUE, PEPTIDE AND GENETICS RESOURCE CORE$292,665
P01 · FY2014 · AG · contact PI